In Korea, pharmacovigilance system is operated on a decentralized basis.
In this system, a central center functions as the focal point for regional centers and collects data from each regional center. These regional centers are called Regional Pharmacovigilance Center (RPVC).
There are 27 RPVCs as of 2016, which are 25 local teaching hospitals and 2 nationwide RPVCs. The nationwide RPVCs include National Medical Center and Korea Pharmaceutical Association, which are linked with nationwide health centers and pharmacies respectively.
Each RPVC monitors AE reports within the center and also outside reports from local clinics and pharmacies. It performs an intensive monitoring on special populations (pediatrics, geriatrics, etc) or special medicinal products designated by MFDS (Ministry of Food and Drug Safety) and offers consultations to reporters and consumers as well. Finally, it emphasizes education and promotional campaigns to stimulate the pharmacovigilance activities.